Please assess the completion status of the following clinical trial:

Trial Title: A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. The patient has a complaint of sore throat.~2. If the patient is a female of childbearing potential, she has been using effective contraception since the last date of menses and is not breast-feeding or lactating.~3. If the patient is a female of childbearing potential, the patient must have a negative urine pregnancy.~4. The patient has provided written informed consent prior to any study-related procedures.~Exclusion Criteria:~1. The patient has a history of an upper gastrointestinal ulcer within the past 60 days, is currently experiencing clinically significant upper gastrointestinal complaints, or is currently taking medication regularly (≥ three times in the previous week).~2. The patient has a history of any hepatic disease or renal dysfunction.~3. The patient has a history of chronic analgesic use (≥ three times per week over the prior four weeks). (Patients on low-dose aspirin therapy may be allowed in the study per investigator's clinical decision.)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- flurbiprofen 8.75 mg lozenge (Type: EXPERIMENTAL): Participants sucked flurbiprofen 8.75mg lozenge every 3-6 hours up to 5 lozenges a day as needed for pain for 7 days.
- Placebo lozenge (Type: PLACEBO_COMPARATOR): Participants sucked vehicle placebo lozenge every 3-6 hours up to 5 lozenges a day as needed for pain for 7 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).